Prudential Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-91,230
| Closed | -$2.03M | – | 2475 |
|
|
2025
Q1 | $2.03M | Sell |
91,230
-690
| -0.8% | -$15.3K | ﹤0.01% | 1278 |
|
|
2024
Q4 | $1.82M | Sell |
91,920
-26,800
| -23% | -$530K | ﹤0.01% | 1334 |
|
|
2024
Q3 | $2.97M | Sell |
118,720
-22,780
| -16% | -$569K | ﹤0.01% | 1248 |
|
|
2024
Q2 | $2.64M | Sell |
141,500
-14,710
| -9% | -$275K | ﹤0.01% | 1267 |
|
|
2024
Q1 | $3.08M | Sell |
156,210
-13,800
| -8% | -$272K | ﹤0.01% | 1197 |
|
|
2023
Q4 | $2.98M | Sell |
170,010
-29,030
| -15% | -$509K | ﹤0.01% | 1195 |
|
|
2023
Q3 | $3.46M | Buy |
199,040
+46,200
| +30% | +$802K | 0.01% | 1067 |
|
|
2023
Q2 | $2.15M | Buy |
152,840
+33,300
| +28% | +$469K | ﹤0.01% | 1359 |
|
|
2023
Q1 | $1.29M | Buy |
119,540
+31,050
| +35% | +$334K | ﹤0.01% | 1604 |
|
|
2022
Q4 | $1.33M | Buy |
88,490
+53,200
| +151% | +$797K | ﹤0.01% | 1555 |
|
|
2022
Q3 | $453K | Buy |
+35,290
| New | +$453K | ﹤0.01% | 2113 |
|